v3.25.2
Stockholders Deficit (Tables)
6 Months Ended
Jun. 30, 2025
Stockholders Deficit  
Summary of warrants valuation assumptions

Expected term (years)

 

 

2.73

 

Expected volatility

 

 

52%

Expected dividends

 

 

0.00%

Risk free interest rate

 

 

4.60%
Summary of warrants

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

Weighted

 

 

Remaining

 

 

Aggregate

 

 

 

Number of

 

 

Average

 

 

Contractual

 

 

Intrinsic

 

Warrants

 

Warrants

 

 

Exercise Price

 

 

Term (Years)

 

 

Value

 

Outstanding - December 31, 2023

 

 

1,000,000

 

 

$3.50

 

 

 

1.57

 

 

$2,500,000

 

Vested and Exercisable - December 31, 2023

 

 

1,000,000

 

 

$3.50

 

 

 

1.57

 

 

$2,500,000

 

Granted

 

 

1,270,000

 

 

$3.50

 

 

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/Forfeited

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding - December 31, 2024

 

 

2,270,000

 

 

$3.50

 

 

 

1.34

 

 

$3,382,300

 

Vested and Exercisable - December 31, 2024

 

 

2,270,000

 

 

$3.50

 

 

 

1.34

 

 

$3,382,300

 

Granted

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled/Forfeited

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding - June 30, 2025

 

 

2,270,000

 

 

$3.50

 

 

 

0.84

 

 

$4,767,000

 

Vested and Exercisable - June 30, 2025

 

 

2,270,000

 

 

$3.50

 

 

 

0.84

 

 

$4,767,000

 

Summary of stock issued for services

Quantity of Series B, preferred stock issued for services

 

 

15,000

 

Conversion ratio of Series B, preferred stock into common stock

 

 

50

 

Equivalent common stock

 

 

750,000

 

Cash offering price for common shares

 

$1.00

 

Value of Series B, preferred stock issued

 

$750,000

 

Quantity of Series B, preferred stock issued majority shareholder

 

 

50,000

 

Conversion ratio of Series B, preferred stock into common stock

 

 

50

 

Equivalent common stock

 

 

2,500,000

 

Cash offering price for common shares

 

$1.00

 

Value of Series B, preferred stock issued

 

$2,500,000